In November 2019, the Italian Society of Endocrinology (SIE) has published a consensus
statement on the tailoring of glucocorticoid replacement in adrenal insufficiency [1]. A few …

A novel coronavirus disease (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has affected over 1,000,000 individuals, claiming more than …

The current COVID-19 pandemic is probably the worst the world has ever faced since the
start of the new millennium. Although the respiratory system is the most prominent target of …

Coronavirus disease 2019 (COVID-19) is well known for its respiratory complications;
however, it can also cause extrapulmonary manifestations, including cardiovascular …

The multifaceted interaction between coronavirus disease 2019 (COVID-19) and the
endocrine system has been a major area of scientific research over the past two years …

Purpose The beneficial effect of glucocorticoids in coronavirus disease (COVID-19) is
established, but whether adrenal cortisol secretion is impaired in COVID-19 is not fully …

We provide guidance on prevention of adrenal crisis during the global COVID-19 crisis, a
time with frequently restricted access to the usual level of healthcare. Patients with adrenal …

Besides the pulmonary manifestations caused by severe acute respiratory syndrome
(SARS) coronavirus 2 (SARS-CoV-2), an emerging endocrine phenotype, which can heavily …

Introduction Evidence on new-onset endocrine dysfunction and identifying whether the
degree of this dysfunction is associated with the severity of disease in patients with COVID …

There is some indication that coronavirus disease 2019 (COVID‐19) causes hypothalamic‐
pituitary‐adrenal axis insufficiency. However, being on glucocorticoids makes it difficult to …